A placebo-controlled study of the safety and efficacy of cabergoline in the treatment of Parkinson's disease

Authors
Category Primary study
Year 1993
This article has no abstract
Epistemonikos ID: a91641e29f8abe929b732836888dd51400ec266e
First added on: Apr 19, 2017